Irritable bowel syndrome following COVID-19: underestimated consequence of infection with SARS-CoV-2

Abstract

Persistent GI symptoms following COVID‑19 are frequent and deserve significant and growing attention of gastroenterologists and other health care practitioners. The Rome IV criteria may be too strict to address the full spectrum of GI symptoms following COVID‑19.